Mein Warenkorb

Granzyme B

Granzyme B Produktliste

  • Attribut

    Kits (2)Protein (1)

  • Produktbibliothek

    Online (2)In Forschung (1)

  • Spezies

    Human (3)

  • Etikett

    - (2)Tag Free (1)

  • Marker

    - (2)Unconjugated (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
CEA-B033
Human
-
Human Granzyme B ELISA Kit In den Warenkorb legen
FCSh-019
Human
-
Human Granzyme B Detection Kit (Flow Cytometry Bead Assay) Vorbestellung
GZB-H5213
Human
HEK293
Human Granzyme B Protein, Tag Free (active enzyme)
In den Warenkorb legen
Gesamtmenge3
  • 1

Granzyme B Molekülhintergrund

Granzyme B (GZMB) is also known as Cathepsin G-like 1 (CTSGL1), Cytotoxic T-lymphocyte proteinase 2 (Lymphocyte protease), Fragmentin-2, Granzyme-2, Human lymphocyte protein (HLP), SECT, CGL1, CSPB, CTLA1, GRB, which belongs to the peptidase S1 family. Granzyme subfamily. GZMB / CTSGL1 contains 1 peptidase S1 domain. The catalytic activity of Granzyme B is “Preferential cleavage: -Asp-|-Xaa- >> -Asn-|-Xaa- > -Met-|-Xaa-, -Ser-|-Xaa-“, and is Inactivated by the serine protease inhibitor diisopropyl fluorophosphates. GZMB is necessary for target cell lysis in cell-mediated immune responses. It cleaves after Asp. GZMB seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution and cleaves caspase-3, -7, -9 and 10 to give rise to active enzymes mediating apoptosis.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
DR-01DR-01Phase 2 ClinicalDren Bio IncLeukemia; Enteropathy-Associated T-Cell Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma; Lymphoma, T-Cell; Bacterial Infections; Autoimmune Diseases of the Nervous System; Leukemia, Large Granular Lymphocytic
Details
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns